News, Events, and Updates

News 03/26/2014

GSK Melanoma Drug Combination Faces Delay In Europe

A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has been delayed in Europe after regulators said they needed more information. March 26, 2014

03/04/2014

Study Uncovers New Pathway of Melanoma Metastas

A new study suggests that in addition to potentially causing tumor-inducing DNA mutations, repetitive exposure to ultraviolet (UV) radiation can cause skin melanoma to metastasize. March 4, 2014  

News 03/03/2014

Durable Melanoma Remission Seen With Bristol Immunotherapy Drug

A drug that uses the body's own immune system to kill cancer cells has produced lasting remissions - some as long as two years - in patients with melanoma that had spread to other parts of the body, according to data. March 3, 2014

News 02/26/2014

Blocking Autophagy With Malaria Drug May Help Overcome Resistance to Melanoma BRAF Drugs

Now, a new preclinical study published online ahead of print in the Journal of Clinical Investigation from Penn Medicine researchers found that in many cases the root of the resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and dabrafenib. February 26, 2014  

News 02/26/2014

Johns Hopkins Researchers Use Tiny Particles to Train immune Systems of Mice to Fight Melanoma

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. February 26, 2014

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.